Adverse event with first-dose perindopril in congestive heart failure (multiple letters) [13]

Lancet

Volumn 350, Issue 9076, 1997, Pages 520-522

  MacFadyen, R J ^a   Lees, K R ^a   Reid, J L ^a   Cleland, J G F ^a   Tan, L B ^a   Wright, D J ^a   Begger, J P ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; PERINDOPRIL; INDOLE DERIVATIVE;

BRAIN INFARCTION; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; HEART INFARCTION; HEMIANOPIA; HUMAN; HYPOTENSION; LETTER; ORTHOSTATIC HYPOTENSION; PATIENT MONITORING; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STROKE; CHEMICALLY INDUCED DISORDER; HEART FAILURE; METHODOLOGY; NOTE; CEREBROVASCULAR DISEASE; DRUG MONITORING; TIME;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; HEART FAILURE; HUMANS; HYPOTENSION; INDOLES; PERINDOPRIL; RESEARCH DESIGN; CEREBROVASCULAR DISORDERS; DRUG MONITORING; TIME FACTORS;

EID: 0030747388     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)63112-1     Document Type: Letter

References (5)

1. JP Bagger Adverse event with first-dose perindopril in congestive heart failure Lancet 349 1997 1671 1672
2. D Annane E Bellisant E Pussard Placebo controlled, randomized double blind study of intravenous enalaprilat efficacy and safety in acute cardiogenic pulmonary edema Circulation 94 1996 1316 1324
3. IB Squire RJ MacFadyen JL Reid A Devlin KR Lees Differing early blood pressure responses to the first dose of an angiotensin converting enzyme inhibitor in congestive heart failure J Cardiovasc Pharmacol 27 1996 657 666
4. G Hillis R Trent P Winton A MacLeod K Jennings Angiotensin converting enzyme inhibitors: are we ignoring the evidence? Quart J Med 89 1996 145 150
5. AR Houghton AJ Cowley The use of angiotensin converting enzyme inhibitors in heart failure by general practitioner: results of a postal survey Eur Heart J 17 suppl 7 1996 61